» Articles » PMID: 34837163

Health Disparities of Cardiometabolic Disorders Among Filipino Americans: Implications for Health Equity and Community-Based Genetic Research

Overview
Date 2021 Nov 27
PMID 34837163
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Health disparities are well-documented among different racial and ethnic minority groups in the United States. Filipino Americans (FAs) are the third-largest Asian-American group in the USA and are commonly grouped under the Asian categorization. FAs have a higher prevalence of cardiometabolic disorders than non-Hispanic Whites and other Asian subgroups with rates comparable to African Americans. Although no major epidemiological studies have ascertained the prevalence of cardiometabolic diseases in FAs, limited reports suggest that FAs have a higher prevalence of dyslipidemia, hypertension, diabetes, metabolic syndrome, hyperuricemia, and gout than non-FAs. A recent genetic study has shown that FAs could have the highest prevalence of a genetic polymorphism strongly associated with the development of gout and gout-related comorbidities. While developing cardiometabolic disorders is a heterogeneous and multifaceted process, the overall prevalence of certain cardiometabolic disorders parallel the prevalence of population-level risk factors, including genetics, dietary lifestyles, health beliefs, and social determinants of health. Therefore, assessment of the Filipino cuisine, health behaviors among Filipinos, socio-cultural factors, and acculturation to living in the USA are equally critical. Ascertaining the contribution of the biological causes to disease onset and the different psychosocial factors that could modulate disease risk or disease management are needed. Ultimately, a multilevel research approach is critical to assess the role of biological and non-biological risk factors of cardiometabolic disorders in FAs to inform culturally appropriate health promotion, disease prevention strategies, and a personalized approach to health.

Citing Articles

Diet Quality, Metabolic Syndrome, and Nativity Status: Elucidating Metabolic Advantage and Disadvantage Among Non-US-Native and US-Native Populations Using NHANES Data (2013-2018).

Smith D, Sakarcan E, Adams-Campbell L, Dash C Nutrients. 2025; 17(2).

PMID: 39861345 PMC: 11767433. DOI: 10.3390/nu17020215.


Exploring socioeconomic status, lifestyle factors, and cardiometabolic disease outcomes in the United States: insights from a population-based cross-sectional study.

Zhou L, Nutakor J, Larnyo E, Addai-Dansoh S, Cui Y, Gavu A BMC Public Health. 2024; 24(1):2174.

PMID: 39134948 PMC: 11318151. DOI: 10.1186/s12889-024-19685-2.


Filipino Immigrants in Santa Cruz de Tenerife, Spain: Health and Access to Services.

Parcon M, Darias-Curvo S, Marrero-Gonzalez C, Sabando-Garcia A Healthcare (Basel). 2024; 12(13).

PMID: 38998852 PMC: 11241225. DOI: 10.3390/healthcare12131317.


U.S. Filipino Adults Have Elevated Prevalence of Hypertension Across the Adult Lifespan: Findings From a Cross-Sectional Electronic Health Record Study.

Gordon N, Lien I, Rana J, Lo J AJPM Focus. 2024; 3(3):100211.

PMID: 38633726 PMC: 11021886. DOI: 10.1016/j.focus.2024.100211.


The Role of Uric Acid in Human Health: Insights from the Gene.

Roman Y J Pers Med. 2023; 13(9).

PMID: 37763176 PMC: 10532990. DOI: 10.3390/jpm13091409.


References
1.
Muncan B . Cardiovascular disease in racial/ethnic minority populations: illness burden and overview of community-based interventions. Public Health Rev. 2018; 39:32. PMC: 6276156. DOI: 10.1186/s40985-018-0109-4. View

2.
Gordon N, Lin T, Rau J, Lo J . Aggregation of Asian-American subgroups masks meaningful differences in health and health risks among Asian ethnicities: an electronic health record based cohort study. BMC Public Health. 2019; 19(1):1551. PMC: 6876105. DOI: 10.1186/s12889-019-7683-3. View

3.
Holland A, Palaniappan L . Problems with the collection and interpretation of Asian-American health data: omission, aggregation, and extrapolation. Ann Epidemiol. 2012; 22(6):397-405. PMC: 4324759. DOI: 10.1016/j.annepidem.2012.04.001. View

4.
Frank A, Zhao B, Jose P, Azar K, Fortmann S, Palaniappan L . Racial/ethnic differences in dyslipidemia patterns. Circulation. 2013; 129(5):570-9. PMC: 4212818. DOI: 10.1161/CIRCULATIONAHA.113.005757. View

5.
Zhang H, De T, Zhong Y, Perera M . The Advantages and Challenges of Diversity in Pharmacogenomics: Can Minority Populations Bring Us Closer to Implementation?. Clin Pharmacol Ther. 2019; 106(2):338-349. PMC: 6663589. DOI: 10.1002/cpt.1491. View